StreetInsider.com News Articles

Form 4 Quantum-Si Inc For: Mar 05 Filed by: Dowdy Paula

Mon, 09 Mar 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260309/26128395.html

Form 4 Quantum-Si Inc For: Mar 05 Filed by: Dowdy Paula

Mon, 09 Mar 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260309/26128395.html

Form 4 Quantum-Si Inc For: Mar 05 Filed by: Kummeth Charles R.

Mon, 09 Mar 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260309/26128396.html

Form 4 Quantum-Si Inc For: Mar 05 Filed by: Kummeth Charles R.

Mon, 09 Mar 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260309/26128396.html

Quantum-SI Inc. (QSI) PT Lowered to $1 at Canaccord

Wed, 04 Mar 2026 06:47:13 -0400

(Updated - March 4, 2026 6:47 AM EST)

Canaccord analyst Kyle Mikson lowered the price target on Quantum-SI Inc. (NASDAQ: QSI) to $1.00 (from $1.50) while maintaining a Hold rating.

The analyst commented: "We reiterate our HOLD rating on Quantum-Si (QSI) shares and lower our price target to $1 from $1.50. After the market close on Wednesday, March 3, the company reported 4Q25 results below our estimates and FactSet consensus. We estimate low-single-digit Platinum instrument sales in the quarter, with gross margin of approximately 27%. Importantly, QSI has largely shifted its focus to the launch of the Proteus platform, framing 2026 as

Quantum-SI Inc. (QSI) PT Lowered to $1 at Canaccord

Wed, 04 Mar 2026 06:47:13 -0400

(Updated - March 4, 2026 6:47 AM EST)

Canaccord analyst Kyle Mikson lowered the price target on Quantum-SI Inc. (NASDAQ: QSI) to $1.00 (from $1.50) while maintaining a Hold rating.

Form S-8 Quantum-Si Inc

Tue, 03 Mar 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260303/26103660.html

Form S-8 Quantum-Si Inc

Tue, 03 Mar 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260303/26103660.html

Form 10-K Quantum-Si Inc For: Dec 31

Tue, 03 Mar 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260303/26102664.html

Form 10-K Quantum-Si Inc For: Dec 31

Tue, 03 Mar 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260303/26102664.html

Form 8-K Quantum-Si Inc For: Mar 03

Tue, 03 Mar 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260303/26101397.html

Form 8-K Quantum-Si Inc For: Mar 03

Tue, 03 Mar 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260303/26101397.html

Quantum-Si incorporated (QSI) Tops Q4 EPS by 4c

Tue, 03 Mar 2026 16:08:02 -0400

Quantum-Si incorporated (NASDAQ: QSI) reported Q4 EPS of ($0.08), $0.04 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $451 thousand versus the consensus estimate of $761.9 thousand.

For earnings history and earnings-related data on Quantum-Si incorporated (QSI) click here.

Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results

Tue, 03 Mar 2026 16:05:00 -0400

Releases List Price of Proteus™ Platform

Reiterates Proteus Development Program On Track for Year End 2026 Launch

Press Release Highlights

Reported fourth quarter revenue of $451,000
Reported on track development of the Proteus platform and related R&D programs to expand proteome coverage and enable broad PTM analysis capabilities
Announced list price for Proteus of $425,000
Announced 2026 Financial Guidance

“2025 was

Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results

Tue, 03 Mar 2026 16:05:00 -0400

Releases List Price of Proteus™ Platform

Reiterates Proteus Development Program On Track for Year End 2026 Launch

Press Release Highlights

Reported fourth quarter revenue of $451,000
Reported on track development of the Proteus platform and related R&D programs to expand proteome coverage and enable broad PTM analysis capabilities
Announced list price for Proteus of $425,000
Announced 2026 Financial Guidance

“2025 was

Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results

Tue, 03 Mar 2026 16:05:00 -0400

Releases List Price of Proteus™ Platform

Reiterates Proteus Development Program On Track for Year End 2026 Launch

Press Release Highlights

Reported fourth quarter revenue of $451,000
Reported on track development of the Proteus platform and related R&D programs to expand proteome coverage and enable broad PTM analysis capabilities
Announced list price for Proteus of $425,000
Announced 2026 Financial Guidance

“2025 was

Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results

Tue, 03 Mar 2026 16:05:00 -0400

Releases List Price of Proteus™ Platform

Reiterates Proteus Development Program On Track for Year End 2026 Launch

Press Release Highlights

Reported fourth quarter revenue of $451,000
Reported on track development of the Proteus platform and related R&D programs to expand proteome coverage and enable broad PTM analysis capabilities
Announced list price for Proteus of $425,000
Announced 2026 Financial Guidance

“2025 was

Form 4 Quantum-Si Inc For: Feb 24 Filed by: Jafri Amir

Thu, 26 Feb 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260226/26070515.html

Form 4 Quantum-Si Inc For: Feb 24 Filed by: Jafri Amir

Thu, 26 Feb 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260226/26070515.html

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fri, 13 Feb 2026 16:05:00 -0400

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 52,296 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended (the “2023 Inducement Plan”). The RSUs were granted as an inducement material to the new employees becoming an employee of Quantum-Si in accordance with Nasdaq Listing Rule 5635(c)(4).

The 2023 Inducement Plan is used exclusively for the

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fri, 13 Feb 2026 16:05:00 -0400

The 2023 Inducement Plan is used exclusively for the

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fri, 13 Feb 2026 16:05:00 -0400

The 2023 Inducement Plan is used exclusively for the

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fri, 13 Feb 2026 16:05:00 -0400

The 2023 Inducement Plan is used exclusively for the

Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Tue, 10 Feb 2026 08:00:00 -0400

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the fourth quarter and full year 2025 on Tuesday, March 3, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET.

Individuals interested in listening to the conference call may do so by joining the live webcast

Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Tue, 10 Feb 2026 08:00:00 -0400

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the fourth quarter and full year 2025 on Tuesday, March 3, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET.

Individuals interested in listening to the conference call may do so by joining the live webcast